Written by experts at the forefront of current research and
clinical practice, this volume provides evidence-based
guidelines for safe, effective, and rational drug therapy in
newborns, children, and adolescents. Coverage includes specific
recommendations for all major drug classes and diseases, a
detailed section on drugs and the newborn, and chapters on
specific treatment settings such as the pediatric intensive care
unit and emergency room. Also included are chapters on adverse
effects and interactions and state-of-the-art discussions on
pharmacokinetics, pharmacodynamics, pharmacogenetics, drug
development, and clinical drug trials in infants and children.
Appendices include a neonatal formulary and a pediatric
formulary.